S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 94 900 KRW 0.74% Market Closed
Market Cap: 1.9T KRW
Have any thoughts about
ST Pharm Co Ltd?
Write Note

ST Pharm Co Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ST Pharm Co Ltd
Total Liabilities & Equity Peer Comparison

Comparables:
207940
F
220100
L
141080
C
268600
E
456070

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
S
ST Pharm Co Ltd
KOSDAQ:237690
Total Liabilities & Equity
â‚©675.4B
CAGR 3-Years
13%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Total Liabilities & Equity
â‚©16.3T
CAGR 3-Years
35%
CAGR 5-Years
23%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Total Liabilities & Equity
â‚©67B
CAGR 3-Years
-5%
CAGR 5-Years
1%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Total Liabilities & Equity
â‚©189.5B
CAGR 3-Years
20%
CAGR 5-Years
9%
CAGR 10-Years
26%
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Total Liabilities & Equity
â‚©26B
CAGR 3-Years
-24%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
E
ENCell Co Ltd
KOSDAQ:456070
Total Liabilities & Equity
â‚©44B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ST Pharm Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
675.4B KRW

Based on the financial report for Jun 30, 2024, ST Pharm Co Ltd's Total Liabilities & Equity amounts to 675.4B KRW.

What is ST Pharm Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
15%

Over the last year, the Total Liabilities & Equity growth was 22%. The average annual Total Liabilities & Equity growth rates for ST Pharm Co Ltd have been 13% over the past three years , 15% over the past five years .

Back to Top